ES2054960T3 - Membrana integral de poli (eter-sulfona), procedimiento para su fabricacion y utilizacion para la ultrafiltracion y microfiltracion. - Google Patents

Membrana integral de poli (eter-sulfona), procedimiento para su fabricacion y utilizacion para la ultrafiltracion y microfiltracion.

Info

Publication number
ES2054960T3
ES2054960T3 ES89115622T ES89115622T ES2054960T3 ES 2054960 T3 ES2054960 T3 ES 2054960T3 ES 89115622 T ES89115622 T ES 89115622T ES 89115622 T ES89115622 T ES 89115622T ES 2054960 T3 ES2054960 T3 ES 2054960T3
Authority
ES
Spain
Prior art keywords
weight
membrane
solvent
cells
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89115622T
Other languages
English (en)
Inventor
Friedbert Wechs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6362099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2054960(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of ES2054960T3 publication Critical patent/ES2054960T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/09—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in organic liquids
    • C08J3/091—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in organic liquids characterised by the chemical constitution of the organic liquid
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • B01D71/66—Polymers having sulfur in the main chain, with or without nitrogen, oxygen or carbon only
    • B01D71/68—Polysulfones; Polyethersulfones
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2381/00—Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing sulfur with or without nitrogen, oxygen, or carbon only; Polysulfones; Derivatives of such polymers
    • C08J2381/06—Polysulfones; Polyethersulfones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Artificial Filaments (AREA)
  • Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)

Abstract

MEMBRANA INTEGRAL DE POLIETERSULFONA CON UN SISTEMA DE POROS ABIERTOS EN SUS LIMITES EXTERIORES, CON FORMA DE PELICULA PLANA, PELICULA TUBULAR O FILAMENTOS HUECOS CON UN DIAMETRO MAXIMO DE LOS POROS DE 0,02 (MU)M A 2 (MU)M, POSEYENDO EL SISTEMA DE POROS FORMA CELULAR CON CELDAS POLIEDRICAS SIMETRICAS LIMITADAS Y ESTANDO DISPUESTAS LAS CELULAS ASIMETRICAMENTE DESDE UNA SUPERFICIE A LA OTRA DE LA MENMBRANA, AL MISMO TIEMPO, QUE EL FACTOR DE ASIMETRIA AF ES, REFERIDO AL DIAMETRO MAXIMO DE LOS POROS, 0,01 A 0,02 Y QUE LA RELACION ENTRE EL CAMINO LIBRE MEDIO MAXIMO DE LA VIA DE PASO Y EL DIAMETRO DEL PORO ES SUPERIOR A 3, VARIANDO EL TAMAÑO DE LAS CELULAS UNIFORMEMENTE DE UNA SUPERFICIE A OTRA. LA MEMBRANA SE FABRICA POR SOLUCION DE UN 12 A 35 % EN PESO, REFERIDO A LA SOLUCION TOTAL, DE POLIETERSULFONA EN UNA MEZCLA FORMADA POR 15 A 65 % EN PESO DE (PERTENECE A) -CAPROLACTAMA, 0 A 85 % EN PESO DE DISOLVENTE LATENTE, 0 A 15 % EN PESO DE PRODUCTO DE ESPESAMIENTO Y 0 A 50 % DE NO DISOLVENTES YEVENTUALMENTE HASTA UN 1% DE PRODUCTOS AUXILIARES, TRANSFORMACION DE LA SOLUCION EN PELICULAS PLANAS, TUBULARES O FILAMETOS HUECOS, CONVERSION EN FASE SOLIDA Y ELIMINACION DE LA MEZCLA, QUE FORMA EL DISOLVENTE. LA MEMBRANA SE UTILIZA PARA ULTRAFILTRADO Y MICROFILTRADO.
ES89115622T 1988-09-01 1989-08-24 Membrana integral de poli (eter-sulfona), procedimiento para su fabricacion y utilizacion para la ultrafiltracion y microfiltracion. Expired - Lifetime ES2054960T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3829752A DE3829752A1 (de) 1988-09-01 1988-09-01 Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration

Publications (1)

Publication Number Publication Date
ES2054960T3 true ES2054960T3 (es) 1994-08-16

Family

ID=6362099

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89115622T Expired - Lifetime ES2054960T3 (es) 1988-09-01 1989-08-24 Membrana integral de poli (eter-sulfona), procedimiento para su fabricacion y utilizacion para la ultrafiltracion y microfiltracion.

Country Status (6)

Country Link
US (1) US4976859A (es)
EP (1) EP0361085B1 (es)
JP (1) JP3068831B2 (es)
AU (1) AU616793B2 (es)
DE (2) DE3829752A1 (es)
ES (1) ES2054960T3 (es)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4112508A1 (de) * 1991-04-17 1992-10-22 Akzo Nv Synthetische hydrophile membranen und verfahren zu deren herstellung
US5788862A (en) * 1992-05-13 1998-08-04 Pall Corporation Filtration medium
US5480554A (en) * 1992-05-13 1996-01-02 Pall Corporation Integrity-testable wet-dry-reversible ultrafiltration membranes and method for testing same
DE4230077A1 (de) * 1992-09-09 1994-03-10 Akzo Nv Polysulfonmembran und Verfahren zu deren Herstellung
US5811224A (en) * 1994-08-24 1998-09-22 Bayer Corporation Process for rejuvenating developer in printing plate development
DE19518624C1 (de) * 1995-05-24 1996-11-21 Akzo Nobel Nv Synthetische Trennmembran
US5837234A (en) * 1995-06-07 1998-11-17 Cytotherapeutics, Inc. Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane
US6299895B1 (en) 1997-03-24 2001-10-09 Neurotech S.A. Device and method for treating ophthalmic diseases
US6027721A (en) * 1996-05-20 2000-02-22 Cytotherapeutics, Inc. Device and method for encapsulated gene therapy
US6054142A (en) * 1996-08-01 2000-04-25 Cyto Therapeutics, Inc. Biocompatible devices with foam scaffolds
US5886059A (en) * 1997-07-08 1999-03-23 Memtec America Corporation Highly asymmetric polyethersulfone filtration membranes
US6303136B1 (en) 1998-04-13 2001-10-16 Neurotech S.A. Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
US6593133B1 (en) 1998-07-06 2003-07-15 Nsgene A/S Neurotrophic factors
US20070071734A1 (en) * 1999-04-06 2007-03-29 Weng Tao ARPE-19 as platform cell line for encapsulated cell-based delivery
US6361771B1 (en) 1999-04-06 2002-03-26 Neurotech S.A. ARPE-19 as a platform cell line for encapsulated cell-based delivery
US6258272B1 (en) * 1999-04-09 2001-07-10 Usf Filtrations And Separations Group, Inc. Internal hydrophilic membranes from blended anionic copolymers
US7108791B2 (en) * 1999-09-14 2006-09-19 Millipore Corporation High-resolution virus removal methodology and filtration capsule useful therefor
US6878543B1 (en) * 1999-10-25 2005-04-12 Nsgene Sa Cultures of GFAP+ nestin+ cells that differentiate to neurons
DE50007011D1 (de) 1999-12-23 2004-08-12 Membrana Gmbh Formkörper zur Pyrogenrückhaltung, Verfahren zu ihrer Herstellung und ihre Verwendung
EP1149625B1 (en) * 2000-04-26 2006-12-06 Pall Corporation Internal hydrophilic membranes from blended anionic copolymers
DE10033401A1 (de) * 2000-07-08 2002-01-17 Univ Twente Fakultaet Chemisch Membran und deren Verwendung
US7442370B2 (en) 2001-02-01 2008-10-28 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
US7276580B2 (en) 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
DK1458853T3 (da) * 2002-05-16 2010-04-06 Absorber Ab Fremgangsmåde til donorspecifik krydsmatchning
JP4571776B2 (ja) * 2002-11-05 2010-10-27 Ｊｘ日鉱日石エネルギー株式会社 潤滑油組成物
EP1897552B1 (en) 2003-04-18 2009-06-17 Biogen Idec MA Inc. Polymer-conjugated glycosylated neublastin
ATE478092T1 (de) 2003-06-10 2010-09-15 Nsgene As Verbesserte sekretion von neublastin
WO2005033297A1 (en) * 2003-09-19 2005-04-14 The Rockefeller University Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells
RU2006117304A (ru) 2003-10-20 2007-12-10 Нсджин А/С (Dk) Генная терапия болезни паркинсона iv vivo
DK1709161T3 (da) * 2004-01-19 2009-01-26 Nsgene As Humane terapeutiske celler, som udskiller nervevækstfaktor
DE102004008219B3 (de) * 2004-02-19 2005-10-27 Membrana Gmbh Integral asymmetrische Membran, Verfahren zu ihrer Herstellung und ihre Verwendung
CA2559110A1 (en) * 2004-03-09 2005-09-15 Absorber Ab Endothelial progenitor cells and methods of use thereof
EP2289911A3 (en) 2004-03-30 2011-03-30 NsGene A/S Therapeutic use of a growth factor, NsG33
US20090136552A1 (en) * 2004-07-30 2009-05-28 Mette Gronborg Growth factors nsg28, nsg30, and nsg32
AU2005277227B2 (en) 2004-08-19 2011-10-06 Biogen Ma Inc. Refolding transforming growth factor beta family proteins
MX2007002029A (es) * 2004-08-19 2007-03-28 Biogen Idec Inc Variantes de neublastina.
US8088567B2 (en) * 2005-04-01 2012-01-03 Nsgene A/S Human immortalised neural precursor cell line
WO2006122551A2 (en) * 2005-05-17 2006-11-23 Nsgene A/S An implantable therapy system for treating a living being with an active factor
DE102005026804B3 (de) * 2005-06-09 2007-02-22 Membrana Gmbh Mikrofiltrationsmembran mit verbessertem Filtrationsverhalten
TW200726474A (en) * 2005-07-15 2007-07-16 Cognate Therapeutics Inc The immunophenotype and immunogenicity of human adipose derived cells
US8357666B2 (en) * 2005-08-01 2013-01-22 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through RNA interference
EP1940471A1 (en) * 2005-10-28 2008-07-09 NsGene A/S IMPLANTABLE BIOCOMPATIBLE IMMtTNOISOLATORY VEHICLE FOR DELIVERY OF GDNF
CA2635534C (en) 2005-12-30 2014-07-29 Neurotech Usa Inc. Micronized device for the delivery of biologically active molecules and methods of use thereof
TWI501774B (zh) * 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
US20100056440A1 (en) * 2006-03-01 2010-03-04 Biogen Idec Ma Inc. Compositions and methods for administering gdnf ligand family proteins
ATE541637T1 (de) 2006-05-06 2012-02-15 Membrana Gmbh Ultrafiltrationsmembran
US9717775B2 (en) 2006-07-18 2017-08-01 University Of Utah Research Foundation Methods for treating pain and screening analgesic compounds
EP2134853B1 (en) 2007-04-03 2018-07-18 Oxyrane UK Limited Glycosylation of molecules
CA2685686A1 (en) 2007-05-01 2008-11-13 Biogen Idec Ma Inc. Neublastin polypeptides for use increasing vascularization in a tissue
WO2009020964A2 (en) * 2007-08-08 2009-02-12 Biogen Idec Ma Inc. Anti-neublastin antibodies and uses thereof
US20090196854A1 (en) * 2008-02-04 2009-08-06 Kytos Biosystems S.A. Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery
EP2274424A4 (en) 2008-04-07 2012-02-01 Nupotential Inc REPROGRAMMING A CELL BY INDUCING A PLURIPOTENT GENE USING AN HDAC MODULATOR
AU2009297565B2 (en) 2008-09-26 2013-10-31 Asahi Kasei Chemicals Corporation Porous membrane, process for producing porous membrane, process for producing clarified liquid, and porous-membrane module
EP3187581A1 (en) 2008-12-23 2017-07-05 BOCO Silicon Valley, Inc. Target populations of oligodendrocyte precursor cells and methods of making and using same
CN102361971A (zh) 2009-01-23 2012-02-22 Ns基因公司 改善的细胞系以及在胶囊化细胞生物递送中的用途
EP2389191A2 (en) 2009-01-23 2011-11-30 NsGene A/S Expression of neuropeptides in mammalian cells
US9511093B2 (en) 2009-03-23 2016-12-06 The Texas A & M University System Compositions of mesenchymal stem cells to regenerate bone
CA2759244A1 (en) * 2009-04-23 2010-10-28 Neurotech Usa, Inc. Cell lines that produce prostaglandin f2 alpha (pgf2a) and uses thereof
BRPI0902039B8 (pt) 2009-06-09 2021-05-25 Anhanguera Educacional Ltda composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais
CA2775938C (en) 2009-09-29 2021-08-10 Oxyrane Uk Limited Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose
JP2013507373A (ja) * 2009-10-08 2013-03-04 ニューロテック ユーエスエー， インコーポレイテッド 被包された細胞ベースの送達系におけるｐｅｄｆの使用
CN102834509A (zh) 2009-11-19 2012-12-19 奥克西雷恩英国有限公司 生成哺乳动物样复合n-聚糖的酵母菌株
EP2563907B1 (en) 2010-04-28 2019-06-19 The J. David Gladstone Institutes Methods for generating cardiomyocytes
WO2011159726A2 (en) 2010-06-14 2011-12-22 The Scripps Research Institute Reprogramming of cells to a new fate
WO2012027494A1 (en) 2010-08-24 2012-03-01 Regents Of The University Of Minnesota Bispecific targeting reagents
WO2012042386A2 (en) 2010-09-29 2012-04-05 Oxyrane Uk Limited Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
EP2622089B1 (en) 2010-09-29 2023-11-01 Oxyrane UK Limited De-mannosylation of phosphorylated n-glycans
KR101886029B1 (ko) 2010-10-01 2018-08-07 호바 세라퓨틱스 에이피에스 무해자극통증, 통각과민증, 자발통증 및 헛통증의 치료를 위한 메테오린의 용도
WO2012075184A2 (en) 2010-12-02 2012-06-07 Neurotech Usa, Inc. Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
WO2012139896A1 (de) 2011-04-13 2012-10-18 Membrana Gmbh Makroporöse filtrationsmembran
RU2637085C2 (ru) 2011-06-06 2017-11-29 КИНЕТА УАН, ЭлЭлСи Фармацевтические композиции на основе shk и способы их получения и использования
CA2867237C (en) 2012-03-15 2024-01-02 Wouter Vervecken Methods and materials for treatment of pompe's disease
KR20150016367A (ko) 2012-05-30 2015-02-11 뉴로테크 유에스에이, 인코포레이티드. 동결보존된 이식형 세포 배양 장치 및 그의 용도
WO2014022376A2 (en) 2012-08-01 2014-02-06 United Therapeutics Corporation Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
JP6901823B2 (ja) 2012-08-01 2021-07-14 ユナイテッド セラピューティクス コーポレイション 間葉系幹細胞による肺動脈性高血圧症の処置
EP3878452B1 (en) 2013-01-09 2023-09-20 United Therapeutics Corporation Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
WO2014136065A2 (en) 2013-03-05 2014-09-12 Oxyrane Uk Limited Production of catalytically active type i sulfatase
JP6234485B2 (ja) 2013-03-07 2017-11-22 ヴィアサイト インコーポレイテッド ３次元大収容力細胞封入デバイスアセンブリー
USD720469S1 (en) 2013-03-07 2014-12-30 Viacyte, Inc. Cell encapsulation device
MX367858B (es) 2013-05-31 2019-09-09 Univ Utah Res Found Péptidos de conotoxina, composiciones farmacéuticas y usos de los mismos.
ES2950987T3 (es) 2013-09-11 2023-10-17 Neurotech Usa Inc Cartucho para terapia con células encapsuladas
WO2015042580A1 (en) 2013-09-23 2015-03-26 Biogen Idec Ma Inc. Compositions and methods for treatment of neuropathic pain
EP2926889A1 (en) * 2014-04-04 2015-10-07 Solvay Specialty Polymers Italy S.p.A. Method for manufacturing polyethersulfone membrane
EP3092987A1 (de) 2015-05-11 2016-11-16 3M Innovative Properties Company System zur wundbehandlung mit serum
US10456356B2 (en) 2015-05-27 2019-10-29 Neurotech Usa, Inc. Use of encapsulated cell therapy for treatment of ophthalmic disorders
EP3349887B1 (en) * 2015-09-17 2022-07-20 Basf Se Process for making membranes using lactamide based solvents
IL266175B2 (en) 2016-10-24 2024-01-01 United Therapeutics Corp Enhancement of immunomodulatory properties of MSC using treprostinil
EP3537986A4 (en) 2016-11-10 2020-06-03 ViaCyte, Inc. PANCREATIC ENDODERM CELLS PDX1 IN CELL DELIVERY DEVICES AND RELATED METHODS
EP3590592A1 (en) 2017-03-01 2020-01-08 NOK Corporation Method for preparing polyphenylsulfone porous hollow fiber membrane
DE102017009784A1 (de) 2017-10-19 2019-04-25 Sartorius Stedim Biotech Gmbh Verfahren zur Herstellung einer porösen einlagigen Polymermembran, poröse einlagige Polymermembran und Verwendung derselben zur Filtration
EP3574986A1 (en) * 2018-05-30 2019-12-04 3M Innovative Properties Company Membrane for capillary microfiltration
US11906252B2 (en) 2019-05-31 2024-02-20 3M Innovative Properties Company Composite cooling film and article including the same
US20220221627A1 (en) 2019-05-31 2022-07-14 3M Innovative Properties Company Composite cooling film and article including the same
EP3838385A1 (en) 2019-12-17 2021-06-23 3M Innovative Properties Company Ultrasonically surface modified polyethersulfone membranes and method of making thereof
US11634613B2 (en) 2019-12-19 2023-04-25 3M Innovative Properties Company Composite cooling film comprising an organic polymeric layer, a UV-absorbing layer, and a reflective metal layer
EP4085174A1 (en) 2019-12-31 2022-11-09 3M Innovative Properties Co. Multi-surface passive cooling articles
US20230213243A1 (en) 2020-05-06 2023-07-06 3M Innovative Properties Company Solar Energy Absorbing and Radiative Cooling Articles and Methods
WO2022208202A1 (en) 2021-03-30 2022-10-06 3M Innovative Properties Company Filtration membrane from a blend comprising polysulfone and polyoxazoline and method of making thereof
WO2023164171A2 (en) 2022-02-25 2023-08-31 Viacyte, Inc. Multilayer implantable cell encapsulation devices and methods thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59581A0 (en) * 1979-03-28 1980-06-30 Monsanto Co Methods for preparing anisotropic membranes and membranes prepared therefrom
JPS5681521A (en) * 1979-12-10 1981-07-03 Toyo Soda Mfg Co Ltd Separation of blood serum and protein
JPS5831204B2 (ja) * 1980-03-10 1983-07-05 日東電工株式会社 ポリスルホン半透膜
DE3161345D1 (en) * 1980-03-28 1983-12-15 Pennwalt Corp Method for preparing a membrane of a film-forming non-sulfonated sulfone polymer
JPS59189903A (ja) * 1983-04-09 1984-10-27 Kanegafuchi Chem Ind Co Ltd 中空糸状フイルタ−およびその製法
DE3327638C2 (de) * 1983-07-30 1986-08-07 Akzo Gmbh, 5600 Wuppertal Verfahren und Vorrichtung zur Herstellung Poren aufweisender Formkörper
NL8303110A (nl) * 1983-09-08 1985-04-01 Tno Werkwijze voor de vervaardiging van asymmetrische membranen voor vloeistof-damp of damp-damp permeatie.
DE3342824A1 (de) * 1983-11-26 1985-06-05 Seitz-Filter-Werke Theo & Geo Seitz GmbH und Co, 6550 Bad Kreuznach Verfahren zum herstellen von filterelementen auf polysulfon-basis
US4780205A (en) * 1984-10-30 1988-10-25 Teijin Limited Permselective hollow fiber membrane, process for the preparation thereof, method and apparatus for plasma components separation
JPS6214905A (ja) * 1985-07-15 1987-01-23 Fuji Photo Film Co Ltd 微孔性膜の製造方法
EP0228072B1 (en) * 1985-12-23 1991-08-28 Gelman Sciences, Inc. Filtration membrane and method of making the same
DE3851572T2 (de) * 1987-06-12 1995-05-24 Kuraray Co Polysulfon-Hohlfasermembran und Verfahren zu ihrer Herstellung.

Also Published As

Publication number Publication date
EP0361085B1 (de) 1993-03-24
AU616793B2 (en) 1991-11-07
JP3068831B2 (ja) 2000-07-24
EP0361085A1 (de) 1990-04-04
DE3829752A1 (de) 1990-03-22
AU4099689A (en) 1990-03-08
DE58903874D1 (de) 1993-04-29
US4976859A (en) 1990-12-11
JPH02211231A (ja) 1990-08-22

Similar Documents

Publication Publication Date Title
ES2054960T3 (es) Membrana integral de poli (eter-sulfona), procedimiento para su fabricacion y utilizacion para la ultrafiltracion y microfiltracion.
FI920133A0 (fi) Film, fiber och mikroporoesa membraner som framstaellts av en poly(etereterketon) upploest i polaera organiska loesningsmedel med hoeg kokpunkt.
IT1063948B (it) Composizioni polimeriche per membrane
ES2057377T3 (es) Sistemas de separacion por membranas hibridas.
ES2138597T3 (es) Procedimiento para la produccion de membranas.
Mulder et al. Ethanol—water separation by pervaporation
US3762136A (en) Preparation of asymmetric polymer membranes
JPS52137026A (en) Microporous hollow fibers and their production
ES2048764T3 (es) Filme microporoso orientado.
EP1153968A4 (en) MICROPOROUS POLYOLEFIN FILM AND METHOD FOR THE PRODUCTION THEREOF
JPS5215627A (en) Porous polypropylene hollow fibers and a process for manufacturing the m
DE69824276D1 (de) Verfahren zur herstellung einer hochdurchlässigen mitroporösen polyolefinische folie
ES2035194T3 (es) Un procedimiento para fabricar membranas asimetricas de permeabilidad selectiva adecuadas para hemodialisis y las membranas asi preparadas.
EP0422251A4 (en) Method of producing modified porous membrane
JPS5417978A (en) Hydrophilic and porous composite structure and its production
SE8002388L (sv) Anisotropa membran och sett att framstella sadana
ATE57100T1 (de) Biologisch-kuenstlicher pankreas unter verwendung von ultrafiltration.
DOP2001000159A (es) Purificación de cuerpos de inclusión de proteina por microfiltracion de flujo cruzado
BR8902218A (pt) Processo para preparacao de membrana de polimero microporosa de celula aberta,processo para formacao de membrana microporosa de celula aberta a membrana microporosa
JPS5468414A (en) Production of porous hollow polypropylene fibers
ES2041395T3 (es) Procedimiento para preparar capas de membranas no porosas.
KR920016135A (ko) 화학 물질 및 열에 대해 내성을 갖는 다공성 반투성 막
JPS5423722A (en) Hollow porous isotactic polypropylene fibers and their production
CA2257503A1 (en) Method of producing microporous polyolefin membrane
JPS54153898A (en) Polyester film

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 361085

Country of ref document: ES